Adaptive Biotechnologies Corp. · 6 hours ago
Material Handler II
Seattle
Full-time
Onsite
Entry Level
$22.74/hr - $27.79/hr
1+ years expAdaptive Biotechnologies is dedicated to harnessing the power of the adaptive immune system to transform disease diagnosis and treatment. As a Material Handler II, you will assist clinical laboratory operations by maintaining inventory levels and performing various tasks related to the storage and distribution of materials. This role requires collaboration with other departments and adherence to regulatory requirements.
BiotechnologyHealth CareTherapeutics
No H1B
Responsibilities
Perform all work in adherence to our standard operating procedures and regulatory requirements such as ISO 13485 and FDA 21CFR Part 820, documenting nonconformances and suggesting improvements as needed
Provide guidance to entry-level staff
If qualified, perform DG /HazMat shipments
Perform structured problem solving to identify root causes and corrective actions
Accurately receive and putaway inbound materials
Pick and prepare orders for outbound shipment
Stock laboratories and warehouse areas
Cycle count materials and investigate variances
Work with appropriate staff to reconcile purchase orders and packing slips
Maintain a clean and orderly work area
Other duties as assigned
Qualification
Required
High School Diploma/Associates degree required
1 year of material handling experience in a highly regulated environment (GMP, ISO etc.)
High attention to detail and ability to adhere to SOP's
A can-do, customer-oriented attitude
Stand for extended periods of time
Lift objects up to 50 pounds
Push and pull wheeled objects up to 800 pounds
Occasionally work in a walk-in freezer (-25°C/-13°F)
Preferred
BS/BA degree preferred
Lean or Six Sigma training preferred
Intermediate experience with Microsoft Word, Excel, and Outlook
Benefits
Equity grant
Bonus eligible
Company
Adaptive Biotechnologies Corp.
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$531.85MKey Investors
OrbiMedARK Investment ManagementMatrix Capital Management
2022-09-12Post Ipo Debt· $125M
2022-03-24Post Ipo Equity
2020-07-14Post Ipo Equity
Leadership Team
Chad Robins
CEO & Co-Founder
Harlan Robins
co-founder and chief Scientific Officer
Recent News
Company data provided by crunchbase